Molecular Spectroscopy for the Biochemical Composition Analysis of Patient‐Derived Pancreatic Cancer Organoids
This investigation underscores the efficacy of molecular spectroscopy as a non-invasive method for profound characterization of PDAC organoids, enhancing our comprehension of tumor biochemistry. The capacity for swift and precise biochemical profiling of PDOs via molecular spectroscopy heralds a promising future for this technique in the realms of cancer diagnostics and personalized medicine.
Authors
- Daniel E. Stange (ORCID: https://orcid.org/0000-0003-4246-2230)
- Grit Preuße
- Jürgen Weitz (ORCID: https://orcid.org/0000-0002-5760-6391)
- Gerald Steiner (ORCID: https://orcid.org/0000-0002-7625-343X)
- Franziska Baenke (ORCID: https://orcid.org/0000-0001-9389-4688)
- Christian Teske (ORCID: https://orcid.org/0000-0002-6049-4765)
- Katja Liedel (ORCID: https://orcid.org/0009-0001-5917-9450)
- Alexander Hirle
Institutions
- German Cancer Research Center (DE)
- Helmholtz-Zentrum Dresden-Rossendorf (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70457
- Primary Topic
- Spectroscopy Techniques in Biomedical and Chemical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wilhelm Sander-Stiftung
- Technische Universität Dresden